Evidence map›Paper›PMID 30206932›Full record

ArticleThe Journal of pathology2019

Cytoplasmic p27

Olivier Calvayrac, Ada Nowosad, Stéphanie Cabantous, Lin-Po Lin, Sarah Figarol, Pauline Jeannot, Murielle P Serres, Caroline Callot, Renaud T Perchey, Justine Creff and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. p27Histology and histopathology · 2025
    Pooled it
  2. Article
  3. Review
  4. Propofol activates AMPK to inhibit the growth of HepG2 cellsJournal of gastrointestinal oncology · 2020
    Article
  5. Article
  6. Review
  7. p27The Journal of pathology · 2019
    Article
  8. Review
4 · The record

Corrections and comments

  • Commented on by
    p272019
5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Olivier CalvayracCancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Ada NowosadLBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.
Stéphanie CabantousCancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Lin-Po LinGraduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan.
Sarah FigarolCancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Pauline JeannotLBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.
Murielle P SerresLBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.
Caroline CallotLBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.
Renaud T PercheyLBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.
Justine CreffLBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.
Estelle Taranchon-ClermontCancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Isabelle RouquetteCancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Gilles FavreCancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Anne PradinesCancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Stephane ManentiCancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Julien MazieresCancer Research Center of Toulouse (CRCT), INSERM U1037, CNRS ERL5294, University of Toulouse, Toulouse, France.
Huei LeeGraduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan.
Arnaud BessonLBCMCP, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse, France.ORCID 0000-0002-9599-3943
Centre National de la Recherche Scientifique · FRTaipei Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cell cycle inhibitor p27

Indexed as

Adenocarcinoma of LungAnimalsCarcinogenesisCarcinoma, Non-Small-Cell LungCyclin-Dependent Kinase Inhibitor p27CytoplasmGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHEK293 CellsHeLa CellsHumansLung NeoplasmsMiceMice, 129 StrainMice, KnockoutProtein BindingCDKN1B protein, humanCdkn1b protein, mouseCyclin-Dependent Kinase Inhibitor p27rhoB GTP-Binding ProteinRHOB protein, humanlung cancernon-small cell lung carcinomap27/Kip1RhoBtransgenic mice

Identifiers

PMID30206932
OpenAlexW2890294297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.